NCI Translational Research Enterprise Will Be Analyzed By New Task Force
This article was originally published in The Pink Sheet Daily
Executive Summary
National Cancer Institute Director von Eschenbach says the task force will examine the landscape of NCI-supported translational research, which includes cancer centers and SPORE programs. The group will identify opportunities to enhance the discovery, development and delivery of cancer therapeutics.